» Download Public Reports
About 300 reports
- Country report
- December 2012
- 8 pages
... Economic space formation. How to increase pharmacy business profitability in the competitive environment 1.A pharmacy trail: a highway or a country road 2.Is there any competition in russian ...
December 2012
... Performance of j.B. Chemicals & pharmaceuticals ltd. That involve risks and uncertainties that could muse actual results to differ materially from those that may be indicated by such statements. ...
November 2012
... For the first nine months in 2011. The gross profit ratio of the segments of ojsc Veropharm Is as stated: group of pharmaceutical products In relation to rx drugs it made 73 ...
November 2012
... For the first nine months in 2011. The gross profit ratio of the segments of ojsc Veropharm Is as stated: group of pharmaceutical products In relation to rx drugs it made 73 ...
December 2012
... Capitalization as 20th december 2012 totaled rur 8.416.000.000 (According to micex). Zao apteki 36.6 Is one of the founding members of the russian association of pharmacy chains (rapc). pharmacy chain 36 ...
December 2012
... Used to treat breast cancer in postmenopausal women, letrozole in the form of 2.5 Mg film-coated tablets is applied when immediate operation is inappropriate. This medicine is also efficient in post ...
February 2013
... Are the same Using of the cros with strong regional presence can decrease the costs Logistics issues (shipment of clinical trial materials to the distant sites: shipment of biosamples to the central lab ...
April 2013
... And + hydrochlorothiazide tablets 50mg+12,5mg azithromycin azithromycin tablets 250mg,500mg,125mg codelac neo tablets butamirate tablets 50mg new products the following new products are expected to be released ...
December 2012
... In consumer traffic and to increase profitability level through the pharmacy chain structure optimization. To achieve the above objectives the company has taken the following steps: in the beginning ...
» Purchase Premium Reports
(From $ 125 - $ 4 863)
About 200 reports
- $ 5 174
- Industry report
- May 2013
- by Global Research & Data Services
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
May 2013
$ 3 750
Purpose of this report was to analyze Russian of pharma. Please pay attention: Benefits of buying the report: ? The report included large volume of information on Russian pharma industry. The report is ...
April 2013
$ 2 800
Keep current with the changing CIS generic and innovative drug segments. Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015. Generic and innovative drug segments in ...
February 2013
$ 2 000
Hepatic (Liver) Tumor - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hepatic (Liver) Tumor - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
April 2013
$ 1 088
Includes 3 FREE quarterly updates BMI View: On the positive side, Russia's pharmaceutical industry should regain double-digit US dollar growth from 2013 and the approval of the country's entry to the WTO ...
May 2013
$ 652
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Russia. The study provides essential market information for decision-makers including: ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...